Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 3 pseudogene 19 (HMGB3P19) is a human pseudogene, meaning it is a segment of DNA that bears high sequence similarity to the coding gene HMGB3, but due to accumulated mutations, it cannot encode a functional protein. Pseudogenes like HMGB3P19 typically arise from gene duplication or retrotransposition events; they lack the regulatory elements or harbor mutations that prevent transcription or translation, and therefore do not have protein-coding capacity or direct biological functions. Although some pseudogenes have regulatory roles or appear as disease biomarkers, there is no evidence that HMGB3P19 is implicated in disease or is considered a drug target[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 3 pseudogene 19 (HMGB3P19).